OLIGOPROGRESSIVE METASTATIC DISEASE
Clinical trials for OLIGOPROGRESSIVE METASTATIC DISEASE explained in plain language.
Never miss a new study
Get alerted when new OLIGOPROGRESSIVE METASTATIC DISEASE trials appear
Sign up with your email to follow new studies for OLIGOPROGRESSIVE METASTATIC DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New triple therapy aims to stop kidney cancer from spreading further
Disease control Recruiting nowThis study tests a new drug (IMSA101) that wakes up the immune system, combined with precise radiation and an immunotherapy drug (nivolumab), for people with metastatic kidney cancer that has started to grow in a few spots. The goal is to see if this combination can delay the can…
Matched conditions: OLIGOPROGRESSIVE METASTATIC DISEASE
Phase: PHASE2 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated May 26, 2026 09:35 UTC
-
Zapping cancer spots may buy time before stronger drugs needed
Disease control Recruiting nowThis study tests whether giving focused radiation (SBRT) to all visible cancer spots, while continuing current medication, can better control prostate cancer than switching to a stronger drug right away. It is for men with castrate-resistant prostate cancer that has spread to a f…
Matched conditions: OLIGOPROGRESSIVE METASTATIC DISEASE
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 26, 2026 09:34 UTC
-
New radiation approach may delay next chemo in spreading cancers
Disease control Recruiting nowThis study tests whether a precise, high-dose radiation technique (SABR) works better than standard low-dose radiation for people with cancer that has spread to a few spots and is starting to grow again. About 194 adults with solid tumors (not lymphoma or myeloma) will be randoml…
Matched conditions: OLIGOPROGRESSIVE METASTATIC DISEASE
Phase: NA • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Radiation boosts failing breast cancer drugs in new trial
Disease control Recruiting nowThis study tests whether precisely targeted radiation (SBRT) can extend the usefulness of current hormone therapy or CDK4/6 inhibitors in women with ER+/HER2- metastatic breast cancer that has started to progress in just 1-3 spots. Participants continue their existing medication …
Matched conditions: OLIGOPROGRESSIVE METASTATIC DISEASE
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Radiation zaps may buy time for melanoma patients
Disease control Recruiting nowThis study is for people with metastatic melanoma whose cancer has started growing in a few spots despite treatment. Researchers want to see if giving high-dose, precise radiation to those spots can delay further spread. About 52 adults will take part, and the main goal is to see…
Matched conditions: OLIGOPROGRESSIVE METASTATIC DISEASE
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New trial zaps spreading cancer spots to keep disease in check
Disease control Recruiting nowThis study is for people with stage IV cancer that has started to grow in a few new places while on standard treatment. Researchers want to see if treating those new spots with local therapies like radiation, surgery, or ablation can help control the disease better than switching…
Matched conditions: OLIGOPROGRESSIVE METASTATIC DISEASE
Phase: PHASE2, PHASE3 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC